Columbia Labs Buys Molecular Profiles for $25M
September 12, 2013 at 07:12 AM EDT
Columbia Laboratories Inc. (Nasdaq: CBRX ) [“Columbia”, the “Company”] has acquired Molecular Profiles Ltd. [“Molecular Profiles”], a privately-held, cash-flow positive, U.K.-based pharmaceutical development services company, for total consideration of approximately $25.0 million comprising $16.7 million in cash and 1,051,323 shares of Columbia common stock, representing ten to eleven times Molecular Profiles' projected EBITDA^1 for